Wearable cardioverter defibrillator after cardiac surgery: Analysis of real‐life data from patients at transient risk of sudden cardiac death
Annals of Noninvasive Electrocardiology · 2023
DOI: 10.1111/anec.13048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Noninvasive Electrocardiology, 2023. Verfasst von Mohamed Elbayomi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Friedrich-Alexander-University, Erlangen, Germany. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiac Surgical Procedures, Tachycardia, Ventricular, Wearable Electronic Devices. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Especially in the first 3 months after cardiac surgery, patients are at transient risk of sudden cardiac death (SCD). To close the gap between hospital discharge and the final implantable cardioverter‐defibrillator (ICD) decision, guidelines recommend temporarily using a wearable cardioverter‐defibrillator (WCD) to protect these patients from SCD. We investigated real‐life data on the safety, effectiveness, and compliance of the WCD in this population.
Methods
Data for analysis were collected via the Zoll Patient Management Network (ZPM) from patients who underwent cardiac surgery and who were discharged with a WCD between 2018 and 2021 at the Cardiac Surgery Center of the University of Erlangen in Germany.
Results
The majority of the 55 patients were male (90.9%) and underwent a coronary artery bypass graft (80.0%). The number of patients with left ventricular ejection fraction (LVEF) >35% increased from 9.1% at the beginning of WCD use to 58.2% at the end of WCD use. Six ventricular tachycardia (VT) episodes occurred in four patients. The WCD appropriately defibrillated two patients with VT episodes. There were no inadequate shocks and no fatalities during the observation time. WCD wearing compliance was high, with a median wear time of 23.3 h/day.
Conclusion
This retrospective analysis in a single cardiac surgery center confirms prior data on the safety and effectiveness of the WCD in patients in post‐surgery care in a real‐life setting. The WCD successfully protected patients from SCD during life‐threatening VT episodes. WCD wearing compliance was high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Friedrich-Alexander-University, Erlangen, Germany.
ORCID-Profile: Mohamed Elbayomi
Zitieren
APA
Elbayomi, M., Weyand, M., Seitz, T., & Harig, F. (2023). Wearable cardioverter defibrillator after cardiac surgery: Analysis of real‐life data from patients at transient risk of sudden cardiac death. Annals of Noninvasive Electrocardiology. https://doi.org/10.1111/anec.13048
Vancouver
Elbayomi M, Weyand M, Seitz T, Harig F. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real‐life data from patients at transient risk of sudden cardiac death. Annals of Noninvasive Electrocardiology. 2023. doi:10.1111/anec.13048
BibTeX
@article{Elbayomi2023,
author = {Elbayomi, Mohamed and Weyand, Michael and Seitz, Timo and Harig, Frank},
title = {Wearable cardioverter defibrillator after cardiac surgery: Analysis of real‐life data from patients at transient risk of sudden cardiac death},
journal = {Annals of Noninvasive Electrocardiology},
year = {2023},
doi = {10.1111/anec.13048}
}
EUVIMED